ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P TSX Capped Composite...
32.47
(
0.28%
)
US Tech 100
15,700.00
(
0.53%
)
S&P 500
4,604.37
(
0.41%
)
US Dollar vs CAD
1.35945
(
0.0%
)
Bitcoin
44,209.22
(
0.06%
)
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Invitae Corporation (NVTA)

  7. Invitae Corporation (NVTA) News

NVTA Invitae Corporation

0.5725
-0.0014 (-0.24%)
Dec 08 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Invitae Corporation NVTA NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.0014 -0.24% 0.5725 18:38:47
Open Price Low Price High Price Close Price Previous Close
0.589 0.5601 0.589 0.5724 0.5739
more quote information »

Recent News

Date Time Source Heading
11/17/202315:48EDGAR2Form 8-K - Current report
11/15/202315:22EDGAR2Form 8-K - Current report
11/14/202318:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/14/202318:55EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/08/202315:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202315:05EDGAR2Form 8-K - Current report
11/08/202315:01PRNUSInvitae Reports Third Quarter 2023 Financial Results
11/06/202315:00PRNUSInvitae Launches Enhanced Chemistry of MRD Test to Better..
11/01/202305:59PRNUSInvitae to Announce Third Quarter 2023 Financial Results on..
10/25/202310:00PRNUSLandmark Study Reveals Magnitude of Uncertain Results in..
10/20/202317:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/19/202315:38EDGAR2Form 8-K - Current report
10/19/202315:30PRNUSInvitae Appoints Dr. David Sholehvar as Chief Operating..
10/12/202315:15PRNUSRural Hospital System Demonstrates the Clinical Benefits of..
10/10/202315:30PRNUSInvitae to Present Data at the National Society of Genetic..
10/03/202311:07PRNUSInvitae's Common Hereditary Cancers Panel Receives FDA..
10/02/202320:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202319:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/29/202319:00DJNFDA Gives Marketing Authorization to Invitae Test for Cancer..
9/27/202315:29EDGAR2Form 8-K - Current report
9/25/202317:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/25/202315:30PRNUSInvitae Announces Appointment of Finance Veteran Ana Schrank..
9/22/202316:02EDGAR2Form 8-K - Current report
9/22/202315:30PRNUSInvitae Receives Notice of Non-Compliance with NYSE Minimum..
9/14/202316:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/28/202315:02PRNUSInvitae Hires Industry Veteran Robert Guigley as Chief..
8/23/202307:12EDGAR2Form 8-K - Current report
8/15/202306:30PRNUSClinical Trial Results Support Genetic Testing of All..
8/14/202315:02PRNUSInvitae Announces Selection of Finance Executive Robert..
8/10/202315:03EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
8/10/202315:01EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
8/09/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
8/09/202308:22EDGAR2Form POS AM - Post-Effective amendments for registration..
8/09/202308:20EDGAR2Form POS AM - Post-Effective amendments for registration..
8/08/202315:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202315:09EDGAR2Form 8-K - Current report
8/08/202315:01PRNUSInvitae Reports Second Quarter 2023 Financial Results
7/26/202315:01PRNUSInvitae to Announce Second Quarter 2023 Financial Results on..
7/05/202315:53EDGAR2Form 8-K - Current report
5/31/202305:59PRNUSInvitae to Present at the William Blair 43rd Annual Growth..
5/26/202307:01PRNUSNew Research Insights to be Presented by Invitae at the 2023..
5/25/202318:00PRNUSInvitae Announces CFO Transition and Selection of Veteran..
5/15/202315:07PRNUSInvitae to Appeal Trial Verdict
5/09/202315:01PRNUSInvitae Reports First Quarter 2023 Financial Results
4/26/202305:59PRNUSInvitae to Announce First Quarter 2023 Financial Results on..
4/17/202315:30PRNUSInvitae Publishes Annual Environmental, Social and..
4/13/202307:45PRNUSNew Study Findings Published in Nature Show Circulating..
3/22/202306:30PRNUSInvitae and Deerfield Management Partner to Create Novel..
3/21/202306:30PRNUSInvitae Announces Partnership with Epic to Streamline..
3/16/202306:30PRNUSInvitae Appoints Dr. W. Michael Korn as Chief Medical..

Your Recent History

NYSE
NVTA
Invitae
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com